A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Nevro Corp stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 17,114 shares of NVRO stock, worth $64,862. This represents 0.02% of its overall portfolio holdings.

Number of Shares
17,114
Previous 225 7506.22%
Holding current value
$64,862
Previous $1.9 Million 4948.39%
% of portfolio
0.02%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.71 - $10.1 $79,547 - $170,578
16,889 Added 7506.22%
17,114 $95.7 Million
Q2 2024

Aug 14, 2024

SELL
$7.96 - $13.59 $50,450 - $86,133
-6,338 Reduced 96.57%
225 $1.9 Million
Q1 2024

May 15, 2024

BUY
$13.56 - $20.78 $88,994 - $136,379
6,563 New
6,563 $94.8 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $134M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Point72 Asia (Singapore) Pte. Ltd. Portfolio

Follow Point72 Asia (Singapore) Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.